Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.86782809 |
2 | NIK/NF-kappaB signaling (GO:0038061) | 5.62378039 |
3 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.45428273 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.44144387 |
5 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.05249027 |
6 | positive regulation of antigen processing and presentation (GO:0002579) | 5.05079865 |
7 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.04858586 |
8 | negative regulation of interleukin-12 production (GO:0032695) | 4.69794945 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.65631486 |
10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.60361852 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.60361852 |
12 | modulation by symbiont of host immune response (GO:0052553) | 4.60361852 |
13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.60361852 |
14 | modulation by symbiont of host defense response (GO:0052031) | 4.60361852 |
15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.60361852 |
16 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.59957849 |
17 | response to muramyl dipeptide (GO:0032495) | 4.59658212 |
18 | regulation of chronic inflammatory response (GO:0002676) | 4.52545328 |
19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50524156 |
20 | neutrophil activation involved in immune response (GO:0002283) | 4.49174499 |
21 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.40471985 |
22 | regulation of antigen processing and presentation (GO:0002577) | 4.35310003 |
23 | myeloid dendritic cell differentiation (GO:0043011) | 4.32588076 |
24 | positive regulation of interleukin-12 production (GO:0032735) | 4.32019341 |
25 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.24986560 |
26 | microglial cell activation (GO:0001774) | 4.12828397 |
27 | immunoglobulin mediated immune response (GO:0016064) | 4.11366114 |
28 | regulation of T-helper cell differentiation (GO:0045622) | 4.06487673 |
29 | macrophage activation involved in immune response (GO:0002281) | 4.02349493 |
30 | myeloid dendritic cell activation (GO:0001773) | 4.01863986 |
31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.98881111 |
32 | regulation of vitamin metabolic process (GO:0030656) | 3.94431687 |
33 | response to peptidoglycan (GO:0032494) | 3.92627475 |
34 | neutrophil activation (GO:0042119) | 3.83760560 |
35 | positive regulation of B cell differentiation (GO:0045579) | 3.83051831 |
36 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.81327656 |
37 | response to protozoan (GO:0001562) | 3.77408939 |
38 | B cell receptor signaling pathway (GO:0050853) | 3.77145687 |
39 | negative thymic T cell selection (GO:0045060) | 3.76101647 |
40 | positive regulation of interferon-alpha production (GO:0032727) | 3.73143063 |
41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.73060293 |
42 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.73060293 |
43 | regulation of T cell tolerance induction (GO:0002664) | 3.72593716 |
44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.71149771 |
45 | mature B cell differentiation (GO:0002335) | 3.70158520 |
46 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.68043059 |
47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.66071505 |
48 | granulocyte activation (GO:0036230) | 3.66026802 |
49 | positive regulation of heat generation (GO:0031652) | 3.65302919 |
50 | eosinophil chemotaxis (GO:0048245) | 3.63574288 |
51 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.63006917 |
52 | regulation of podosome assembly (GO:0071801) | 3.61332123 |
53 | regulation of fever generation (GO:0031620) | 3.60725893 |
54 | regulation of interferon-alpha production (GO:0032647) | 3.58787212 |
55 | dendritic cell differentiation (GO:0097028) | 3.57818318 |
56 | positive regulation of macrophage cytokine production (GO:0060907) | 3.57557500 |
57 | * regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.54977190 |
58 | regulation of interleukin-12 production (GO:0032655) | 3.54313122 |
59 | germinal center formation (GO:0002467) | 3.53837047 |
60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.50362843 |
61 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.48585593 |
62 | natural killer cell mediated immunity (GO:0002228) | 3.48585593 |
63 | negative T cell selection (GO:0043383) | 3.45312937 |
64 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.43739894 |
65 | positive regulation of type 2 immune response (GO:0002830) | 3.41640172 |
66 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.40892077 |
67 | * positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.39862541 |
68 | regulation of chemokine biosynthetic process (GO:0045073) | 3.36208090 |
69 | positive thymic T cell selection (GO:0045059) | 3.35622642 |
70 | regulation of B cell differentiation (GO:0045577) | 3.33639039 |
71 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.32945056 |
72 | cellular extravasation (GO:0045123) | 3.32708135 |
73 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.31031264 |
74 | regulation of T-helper 1 type immune response (GO:0002825) | 3.30828180 |
75 | myeloid cell activation involved in immune response (GO:0002275) | 3.29273623 |
76 | negative regulation of cell killing (GO:0031342) | 3.28364397 |
77 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.28364397 |
78 | regulation of mononuclear cell migration (GO:0071675) | 3.27439890 |
79 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.26877098 |
80 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.22132057 |
81 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.21972909 |
82 | cellular response to zinc ion (GO:0071294) | 3.20904621 |
83 | cellular response to interferon-gamma (GO:0071346) | 3.20341796 |
84 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.20005844 |
85 | T-helper cell differentiation (GO:0042093) | 3.20005844 |
86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.17961520 |
87 | respiratory burst (GO:0045730) | 3.17913784 |
88 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.17407080 |
89 | eosinophil migration (GO:0072677) | 3.17167369 |
90 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16845196 |
91 | negative regulation of granulocyte differentiation (GO:0030853) | 3.16171927 |
92 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.14275136 |
93 | positive regulation of neutrophil migration (GO:1902624) | 3.14275136 |
94 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.13613110 |
95 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.11691408 |
96 | * regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.10777944 |
97 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.09529248 |
98 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.08557782 |
99 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.07558313 |
100 | B cell mediated immunity (GO:0019724) | 3.07550236 |
101 | negative regulation of interleukin-17 production (GO:0032700) | 3.07067278 |
102 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.06411396 |
103 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.06358139 |
104 | T cell migration (GO:0072678) | 3.06313193 |
105 | cellular response to lipopolysaccharide (GO:0071222) | 3.05887263 |
106 | macrophage activation (GO:0042116) | 3.05757632 |
107 | B cell homeostasis (GO:0001782) | 3.05518929 |
108 | myeloid leukocyte activation (GO:0002274) | 3.04979978 |
109 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.03647061 |
110 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.02344588 |
111 | regulation of type 2 immune response (GO:0002828) | 3.02318632 |
112 | regulation of activation of Janus kinase activity (GO:0010533) | 3.01803382 |
113 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.01530653 |
114 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.00960115 |
115 | positive regulation of interleukin-17 production (GO:0032740) | 3.00327596 |
116 | response to interferon-gamma (GO:0034341) | 2.99919740 |
117 | monocyte chemotaxis (GO:0002548) | 2.99659995 |
118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.99233337 |
119 | cellular response to molecule of bacterial origin (GO:0071219) | 2.97840568 |
120 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.97450497 |
121 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.97000719 |
122 | positive regulation of humoral immune response (GO:0002922) | 2.96782143 |
123 | type I interferon signaling pathway (GO:0060337) | 2.95786762 |
124 | cellular response to type I interferon (GO:0071357) | 2.95786762 |
125 | cytokine secretion (GO:0050663) | 2.95362872 |
126 | negative regulation of interleukin-10 production (GO:0032693) | 2.94924864 |
127 | response to type I interferon (GO:0034340) | 2.92218032 |
128 | negative regulation of growth of symbiont in host (GO:0044130) | 2.92065597 |
129 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.92065597 |
130 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.92065597 |
131 | regulation of growth of symbiont in host (GO:0044126) | 2.92065597 |
132 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.91998934 |
133 | * positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.91652340 |
134 | T cell activation involved in immune response (GO:0002286) | 2.88667763 |
135 | regulation of B cell proliferation (GO:0030888) | 2.88022508 |
136 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.87157950 |
137 | lymphocyte chemotaxis (GO:0048247) | 2.86752197 |
138 | positive regulation of B cell proliferation (GO:0030890) | 2.86312058 |
139 | negative regulation of B cell proliferation (GO:0030889) | 2.86254064 |
140 | regulation of tolerance induction (GO:0002643) | 2.86091549 |
141 | defense response to protozoan (GO:0042832) | 2.85486665 |
142 | T-helper 1 type immune response (GO:0042088) | 2.85367018 |
143 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83704503 |
144 | positive regulation of defense response to virus by host (GO:0002230) | 2.83637277 |
145 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.83635812 |
146 | regulation of RIG-I signaling pathway (GO:0039535) | 2.83615199 |
147 | mature B cell differentiation involved in immune response (GO:0002313) | 2.83286196 |
148 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83028266 |
149 | response to host immune response (GO:0052572) | 2.83028266 |
150 | leukocyte mediated cytotoxicity (GO:0001909) | 2.82971372 |
151 | dendritic cell chemotaxis (GO:0002407) | 2.82952989 |
152 | lymphocyte mediated immunity (GO:0002449) | 2.82448833 |
153 | * positive regulation of interleukin-2 production (GO:0032743) | 2.82134195 |
154 | positive regulation of interferon-beta production (GO:0032728) | 2.81805245 |
155 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81144424 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.89534357 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.90048740 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.79540478 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.50659586 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.37478976 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.10707353 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.99732821 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.84983264 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.57189691 |
10 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.42178654 |
11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.36773020 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.29552912 |
13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.19227394 |
14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.15079976 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13073505 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.10029639 |
17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.91310209 |
18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.60845603 |
19 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53447615 |
20 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.52758789 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50052601 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29321925 |
23 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25644396 |
24 | MYB_26560356_Chip-Seq_TH2_Human | 2.18686691 |
25 | MAF_26560356_Chip-Seq_TH1_Human | 2.06630262 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03076727 |
27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96694561 |
28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.95633873 |
29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89589628 |
30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87549332 |
31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.86901509 |
32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86533940 |
33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86441295 |
34 | MYB_26560356_Chip-Seq_TH1_Human | 1.77315440 |
35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73879801 |
36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.73334221 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72457207 |
38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.72182697 |
39 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.62445026 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56511609 |
41 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54744045 |
42 | MYC_22102868_ChIP-Seq_BL_Human | 1.53154879 |
43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48457514 |
44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48385517 |
45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47821177 |
46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44884188 |
47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35866656 |
48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34731603 |
49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33750471 |
50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30883483 |
51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29539165 |
52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27212197 |
53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22133840 |
54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19895824 |
55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19052396 |
56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18422701 |
57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18116157 |
58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16663934 |
59 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15227462 |
60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15068768 |
61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14160282 |
62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11817525 |
63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11633642 |
64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11361420 |
65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10729582 |
66 | MAF_26560356_Chip-Seq_TH2_Human | 1.08656978 |
67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08388649 |
68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06571126 |
69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04599838 |
70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03156776 |
71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02470513 |
72 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.00796461 |
73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99729062 |
74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99463474 |
75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95273611 |
76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95236538 |
77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94418622 |
78 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92866007 |
79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92293479 |
80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91097796 |
81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89311038 |
82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88809956 |
83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88452636 |
84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87322569 |
85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86202630 |
86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84184839 |
87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79961719 |
88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79945081 |
89 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79708153 |
90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79645465 |
91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78996194 |
92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76366215 |
93 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73025015 |
94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72511885 |
95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72480926 |
96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.72065068 |
97 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.71546132 |
98 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69792977 |
99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.68527640 |
100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68390872 |
101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67981958 |
102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.67624086 |
103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.67522349 |
104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.67522349 |
105 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.67195525 |
106 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.65690845 |
107 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65636986 |
108 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.63848463 |
109 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63599886 |
110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61965431 |
111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.61286140 |
112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60839049 |
113 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.59987152 |
114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57711837 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.42941250 |
2 | MP0004510_myositis | 3.69550872 |
3 | MP0001790_abnormal_immune_system | 3.61262502 |
4 | MP0005387_immune_system_phenotype | 3.61262502 |
5 | MP0000685_abnormal_immune_system | 3.59671989 |
6 | MP0003303_peritoneal_inflammation | 3.46306245 |
7 | MP0003436_decreased_susceptibility_to | 3.39136223 |
8 | MP0005671_abnormal_response_to | 3.33048573 |
9 | * MP0002148_abnormal_hypersensitivity_rea | 3.27744478 |
10 | * MP0001800_abnormal_humoral_immune | 3.26251800 |
11 | MP0005000_abnormal_immune_tolerance | 3.26204910 |
12 | MP0002254_reproductive_system_inflammat | 3.11776648 |
13 | MP0002138_abnormal_hepatobiliary_system | 3.02121241 |
14 | * MP0002452_abnormal_antigen_presenting | 2.97367668 |
15 | MP0009785_altered_susceptibility_to | 2.86843784 |
16 | MP0002419_abnormal_innate_immunity | 2.77573154 |
17 | * MP0002723_abnormal_immune_serum | 2.75369915 |
18 | MP0005025_abnormal_response_to | 2.50520689 |
19 | * MP0001819_abnormal_immune_cell | 2.49230218 |
20 | * MP0002420_abnormal_adaptive_immunity | 2.47953558 |
21 | MP0001853_heart_inflammation | 2.34096498 |
22 | MP0005310_abnormal_salivary_gland | 2.26440830 |
23 | MP0002166_altered_tumor_susceptibility | 2.13752746 |
24 | MP0006082_CNS_inflammation | 2.05663541 |
25 | MP0005058_abnormal_lysosome_morphology | 2.05098482 |
26 | MP0002139_abnormal_hepatobiliary_system | 2.01206203 |
27 | MP0002405_respiratory_system_inflammati | 1.98880918 |
28 | MP0000569_abnormal_digit_pigmentation | 1.88242959 |
29 | * MP0000716_abnormal_immune_system | 1.88187169 |
30 | * MP0002398_abnormal_bone_marrow | 1.85421344 |
31 | MP0005451_abnormal_body_composition | 1.84786963 |
32 | MP0005464_abnormal_platelet_physiology | 1.79361569 |
33 | MP0002006_tumorigenesis | 1.77329548 |
34 | MP0003300_gastrointestinal_ulcer | 1.74356003 |
35 | MP0001348_abnormal_lacrimal_gland | 1.73739819 |
36 | MP0001845_abnormal_inflammatory_respons | 1.72227546 |
37 | MP0004947_skin_inflammation | 1.67715969 |
38 | MP0010155_abnormal_intestine_physiology | 1.63584041 |
39 | MP0002277_abnormal_respiratory_mucosa | 1.60891268 |
40 | MP0003191_abnormal_cellular_cholesterol | 1.60714451 |
41 | MP0003195_calcinosis | 1.60296429 |
42 | MP0000689_abnormal_spleen_morphology | 1.56580062 |
43 | MP0001533_abnormal_skeleton_physiology | 1.52885377 |
44 | MP0003724_increased_susceptibility_to | 1.47966531 |
45 | MP0008004_abnormal_stomach_pH | 1.47434149 |
46 | * MP0002429_abnormal_blood_cell | 1.47096719 |
47 | MP0002722_abnormal_immune_system | 1.44631965 |
48 | MP0003172_abnormal_lysosome_physiology | 1.43391748 |
49 | MP0002163_abnormal_gland_morphology | 1.39246950 |
50 | MP0001873_stomach_inflammation | 1.37687185 |
51 | MP0003448_altered_tumor_morphology | 1.36998272 |
52 | MP0008469_abnormal_protein_level | 1.36864681 |
53 | MP0009764_decreased_sensitivity_to | 1.35550355 |
54 | MP0003763_abnormal_thymus_physiology | 1.35497263 |
55 | MP0008057_abnormal_DNA_replication | 1.30214768 |
56 | MP0005076_abnormal_cell_differentiation | 1.29348176 |
57 | MP0009840_abnormal_foam_cell | 1.23767258 |
58 | MP0000604_amyloidosis | 1.23333955 |
59 | MP0003183_abnormal_peptide_metabolism | 1.22776597 |
60 | MP0009333_abnormal_splenocyte_physiolog | 1.13460803 |
61 | MP0003075_altered_response_to | 1.12261938 |
62 | MP0009278_abnormal_bone_marrow | 1.06019093 |
63 | MP0002332_abnormal_exercise_endurance | 1.05216941 |
64 | MP0003656_abnormal_erythrocyte_physiolo | 1.03972605 |
65 | MP0001545_abnormal_hematopoietic_system | 1.03563815 |
66 | MP0005397_hematopoietic_system_phenotyp | 1.03563815 |
67 | MP0003806_abnormal_nucleotide_metabolis | 1.02714366 |
68 | MP0003828_pulmonary_edema | 1.01484894 |
69 | MP0002009_preneoplasia | 1.00673718 |
70 | MP0003091_abnormal_cell_migration | 1.00334450 |
71 | MP0002877_abnormal_melanocyte_morpholog | 1.00141732 |
72 | MP0000703_abnormal_thymus_morphology | 0.99845859 |
73 | MP0002933_joint_inflammation | 0.99412173 |
74 | MP0002998_abnormal_bone_remodeling | 0.97063752 |
75 | MP0000858_altered_metastatic_potential | 0.96540324 |
76 | MP0000343_altered_response_to | 0.92616058 |
77 | MP0003453_abnormal_keratinocyte_physiol | 0.85910021 |
78 | MP0005647_abnormal_sex_gland | 0.83918033 |
79 | MP0009765_abnormal_xenobiotic_induced | 0.83328127 |
80 | MP0001851_eye_inflammation | 0.82177413 |
81 | MP0005174_abnormal_tail_pigmentation | 0.81052754 |
82 | MP0010352_gastrointestinal_tract_polyps | 0.80885353 |
83 | MP0003866_abnormal_defecation | 0.80516644 |
84 | MP0000249_abnormal_blood_vessel | 0.77933378 |
85 | MP0004808_abnormal_hematopoietic_stem | 0.77252133 |
86 | MP0003690_abnormal_glial_cell | 0.76873823 |
87 | MP0000465_gastrointestinal_hemorrhage | 0.76711792 |
88 | MP0000920_abnormal_myelination | 0.75130300 |
89 | MP0009763_increased_sensitivity_to | 0.74672831 |
90 | MP0001501_abnormal_sleep_pattern | 0.74516906 |
91 | MP0000371_diluted_coat_color | 0.72657758 |
92 | MP0003045_fibrosis | 0.71959220 |
93 | MP0010307_abnormal_tumor_latency | 0.71787030 |
94 | MP0005167_abnormal_blood-brain_barrier | 0.71757497 |
95 | MP0006054_spinal_hemorrhage | 0.71021642 |
96 | MP0005379_endocrine/exocrine_gland_phen | 0.70565664 |
97 | MP0002396_abnormal_hematopoietic_system | 0.70138958 |
98 | MP0002136_abnormal_kidney_physiology | 0.69171848 |
99 | MP0005165_increased_susceptibility_to | 0.68672392 |
100 | MP0000767_abnormal_smooth_muscle | 0.68271232 |
101 | MP0002928_abnormal_bile_duct | 0.67736018 |
102 | MP0005390_skeleton_phenotype | 0.66899507 |
103 | MP0005166_decreased_susceptibility_to | 0.66823849 |
104 | MP0008874_decreased_physiological_sensi | 0.66103686 |
105 | MP0003566_abnormal_cell_adhesion | 0.63274748 |
106 | MP0008260_abnormal_autophagy | 0.60968518 |
107 | MP0001346_abnormal_lacrimal_gland | 0.60309675 |
108 | MP0005164_abnormal_response_to | 0.58913428 |
109 | MP0003329_amyloid_beta_deposits | 0.57345497 |
110 | MP0004883_abnormal_blood_vessel | 0.55205729 |
111 | MP0003646_muscle_fatigue | 0.53877228 |
112 | MP0004742_abnormal_vestibular_system | 0.52259370 |
113 | MP0000490_abnormal_crypts_of | 0.52238925 |
114 | MP0002693_abnormal_pancreas_physiology | 0.51325160 |
115 | MP0000609_abnormal_liver_physiology | 0.49136647 |
116 | MP0001879_abnormal_lymphatic_vessel | 0.48598257 |
117 | MP0003795_abnormal_bone_structure | 0.42857149 |
118 | MP0001663_abnormal_digestive_system | 0.42757376 |
119 | MP0001191_abnormal_skin_condition | 0.42741741 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.28934048 |
2 | Recurrent bacterial skin infections (HP:0005406) | 6.07042885 |
3 | Eczematoid dermatitis (HP:0000976) | 5.55255460 |
4 | Systemic lupus erythematosus (HP:0002725) | 5.48054503 |
5 | Optic neuritis (HP:0100653) | 4.32929741 |
6 | Retrobulbar optic neuritis (HP:0100654) | 4.32929741 |
7 | Mediastinal lymphadenopathy (HP:0100721) | 4.29193711 |
8 | Colitis (HP:0002583) | 4.22151042 |
9 | Orchitis (HP:0100796) | 4.11489577 |
10 | Glomerulonephritis (HP:0000099) | 4.08705797 |
11 | Recurrent fungal infections (HP:0002841) | 4.07970934 |
12 | Myositis (HP:0100614) | 4.06261497 |
13 | Agammaglobulinemia (HP:0004432) | 4.05354414 |
14 | Recurrent viral infections (HP:0004429) | 4.01231694 |
15 | Recurrent skin infections (HP:0001581) | 3.98541464 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93748703 |
17 | Loss of speech (HP:0002371) | 3.93386830 |
18 | Vasculitis (HP:0002633) | 3.85971515 |
19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.82167743 |
20 | Cellulitis (HP:0100658) | 3.80723226 |
21 | Pulmonary infiltrates (HP:0002113) | 3.79106586 |
22 | Abnormality of macrophages (HP:0004311) | 3.74451654 |
23 | Vacuolated lymphocytes (HP:0001922) | 3.62611081 |
24 | Chronic otitis media (HP:0000389) | 3.55512149 |
25 | Mutism (HP:0002300) | 3.55194128 |
26 | Increased cerebral lipofuscin (HP:0011813) | 3.51071168 |
27 | Hematochezia (HP:0002573) | 3.49202578 |
28 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.44084051 |
29 | Myocardial infarction (HP:0001658) | 3.41990019 |
30 | Inflammation of the large intestine (HP:0002037) | 3.35054976 |
31 | Gastrointestinal stroma tumor (HP:0100723) | 3.33304853 |
32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.21831039 |
33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.21831039 |
34 | Stomatitis (HP:0010280) | 3.17914016 |
35 | Autoimmune thrombocytopenia (HP:0001973) | 3.13922699 |
36 | Gingivitis (HP:0000230) | 3.12488865 |
37 | Meningitis (HP:0001287) | 3.10149468 |
38 | Arterial thrombosis (HP:0004420) | 3.07366840 |
39 | Gastrointestinal inflammation (HP:0004386) | 3.07165149 |
40 | Recurrent bronchitis (HP:0002837) | 3.06216485 |
41 | Gastrointestinal infarctions (HP:0005244) | 3.06200987 |
42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05189398 |
43 | Gangrene (HP:0100758) | 3.03793157 |
44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99641842 |
45 | Obstructive lung disease (HP:0006536) | 2.99641842 |
46 | Increased IgM level (HP:0003496) | 2.91211937 |
47 | Panhypogammaglobulinemia (HP:0003139) | 2.90470490 |
48 | Recurrent pneumonia (HP:0006532) | 2.85546285 |
49 | Leukocytosis (HP:0001974) | 2.83591755 |
50 | Osteomyelitis (HP:0002754) | 2.82935057 |
51 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81248957 |
52 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81248957 |
53 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81248957 |
54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.78555863 |
55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.78555863 |
56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.78555863 |
57 | Basal ganglia calcification (HP:0002135) | 2.78141785 |
58 | Eosinophilia (HP:0001880) | 2.73580780 |
59 | Thyroiditis (HP:0100646) | 2.72131584 |
60 | Periodontitis (HP:0000704) | 2.71209983 |
61 | Spontaneous hematomas (HP:0007420) | 2.70636605 |
62 | Keratoconjunctivitis sicca (HP:0001097) | 2.68021742 |
63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65171424 |
64 | Mucopolysacchariduria (HP:0008155) | 2.65171424 |
65 | T lymphocytopenia (HP:0005403) | 2.64466204 |
66 | Recurrent lower respiratory tract infections (HP:0002783) | 2.63879286 |
67 | Complement deficiency (HP:0004431) | 2.62390109 |
68 | Increased serum ferritin (HP:0003281) | 2.59422692 |
69 | Interstitial pulmonary disease (HP:0006530) | 2.57715893 |
70 | Amaurosis fugax (HP:0100576) | 2.54773316 |
71 | Apathy (HP:0000741) | 2.54303666 |
72 | Autoimmune hemolytic anemia (HP:0001890) | 2.53900494 |
73 | Emphysema (HP:0002097) | 2.52592818 |
74 | Nasal polyposis (HP:0100582) | 2.51628856 |
75 | Abnormality of complement system (HP:0005339) | 2.50144190 |
76 | Dysostosis multiplex (HP:0000943) | 2.49966089 |
77 | Diminished motivation (HP:0000745) | 2.49061846 |
78 | Fatigue (HP:0012378) | 2.48456775 |
79 | Polyneuropathy (HP:0001271) | 2.47445680 |
80 | Prostate neoplasm (HP:0100787) | 2.46208391 |
81 | Amyloidosis (HP:0011034) | 2.45176608 |
82 | Keratoconjunctivitis (HP:0001096) | 2.44954244 |
83 | IgM deficiency (HP:0002850) | 2.41105159 |
84 | Pustule (HP:0200039) | 2.40705846 |
85 | Neurofibrillary tangles (HP:0002185) | 2.39928690 |
86 | Osteolytic defects of the hand bones (HP:0009699) | 2.39345394 |
87 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39345394 |
88 | IgA deficiency (HP:0002720) | 2.38540732 |
89 | Chronic diarrhea (HP:0002028) | 2.37948365 |
90 | Increased IgE level (HP:0003212) | 2.37063366 |
91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36702933 |
92 | Disinhibition (HP:0000734) | 2.36366635 |
93 | Abnormality of T cell number (HP:0011839) | 2.35178033 |
94 | Chronic sinusitis (HP:0011109) | 2.34702457 |
95 | Lymphopenia (HP:0001888) | 2.34571020 |
96 | Thick nail (HP:0001805) | 2.33704728 |
97 | Hypergammaglobulinemia (HP:0010702) | 2.31858944 |
98 | Agnosia (HP:0010524) | 2.31224467 |
99 | Nephritis (HP:0000123) | 2.30980243 |
100 | Abnormality of eosinophils (HP:0001879) | 2.30493568 |
101 | Encephalitis (HP:0002383) | 2.30364075 |
102 | Granulocytopenia (HP:0001913) | 2.29611448 |
103 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.29587500 |
104 | Hemoptysis (HP:0002105) | 2.26781419 |
105 | Neuronal loss in central nervous system (HP:0002529) | 2.26676929 |
106 | Nuclear cataract (HP:0100018) | 2.25840225 |
107 | Recurrent sinusitis (HP:0011108) | 2.25791645 |
108 | Abnormality of the prostate (HP:0008775) | 2.24776899 |
109 | Axonal loss (HP:0003447) | 2.23531692 |
110 | Anorexia (HP:0002039) | 2.20449255 |
111 | Abnormality of the pleura (HP:0002103) | 2.16919536 |
112 | Gingival bleeding (HP:0000225) | 2.15639039 |
113 | Hypertensive crisis (HP:0100735) | 2.15209314 |
114 | Nausea (HP:0002018) | 2.14818619 |
115 | Thrombocytosis (HP:0001894) | 2.14281966 |
116 | Arthralgia (HP:0002829) | 2.13891014 |
117 | Urticaria (HP:0001025) | 2.13276013 |
118 | Purpura (HP:0000979) | 2.13251165 |
119 | Abnormality of the nasal mucosa (HP:0000433) | 2.13186502 |
120 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.11110267 |
121 | IgG deficiency (HP:0004315) | 2.07999115 |
122 | Verrucae (HP:0200043) | 2.07963366 |
123 | Papilloma (HP:0012740) | 2.07963366 |
124 | Restrictive lung disease (HP:0002091) | 2.07340105 |
125 | Inappropriate behavior (HP:0000719) | 2.07127712 |
126 | Progressive neurologic deterioration (HP:0002344) | 2.06418461 |
127 | Memory impairment (HP:0002354) | 2.03749621 |
128 | Chest pain (HP:0100749) | 2.03609554 |
129 | B lymphocytopenia (HP:0010976) | 1.99921941 |
130 | Abnormality of B cell number (HP:0010975) | 1.99685288 |
131 | Hepatosplenomegaly (HP:0001433) | 1.99393575 |
132 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.99268138 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 5.63430933 |
2 | TYK2 | 3.63743181 |
3 | IKBKB | 3.49532858 |
4 | TBK1 | 3.40356449 |
5 | RIPK4 | 3.38315639 |
6 | MAP4K1 | 3.28492712 |
7 | BLK | 3.01266443 |
8 | MAP3K13 | 2.86444549 |
9 | NME2 | 2.75212534 |
10 | IRAK3 | 2.68014801 |
11 | IKBKE | 2.62396914 |
12 | CHUK | 2.55475695 |
13 | IRAK4 | 2.54331205 |
14 | PRPF4B | 2.38971542 |
15 | JAK1 | 2.34599720 |
16 | TAOK2 | 2.33386117 |
17 | MAP3K10 | 2.29467260 |
18 | JAK3 | 2.26402693 |
19 | CSF1R | 2.20366161 |
20 | DDR2 | 2.16111334 |
21 | TGFBR2 | 2.02984582 |
22 | KIT | 2.00545672 |
23 | EPHB1 | 1.79624292 |
24 | SYK | 1.69473025 |
25 | ADRBK2 | 1.51615612 |
26 | ZAP70 | 1.48164447 |
27 | BTK | 1.46306947 |
28 | CSK | 1.44954229 |
29 | CAMK1D | 1.44748411 |
30 | EPHA3 | 1.42164025 |
31 | TXK | 1.40310226 |
32 | BMPR2 | 1.38006296 |
33 | MST4 | 1.36530983 |
34 | PDK2 | 1.31246624 |
35 | TAOK3 | 1.29140219 |
36 | MAPK15 | 1.28868191 |
37 | HCK | 1.28338137 |
38 | TAOK1 | 1.27331303 |
39 | GRK6 | 1.26392573 |
40 | IRAK2 | 1.25851621 |
41 | CDC42BPA | 1.22574389 |
42 | PIM1 | 1.20214646 |
43 | ITK | 1.17299017 |
44 | LYN | 1.16909671 |
45 | LCK | 1.16731749 |
46 | JAK2 | 1.14570579 |
47 | PIM2 | 1.13320727 |
48 | RIPK1 | 1.09603363 |
49 | FGFR4 | 1.08867699 |
50 | STK10 | 1.07664328 |
51 | MATK | 1.05657435 |
52 | FGFR3 | 1.03799578 |
53 | MAP2K3 | 1.02465228 |
54 | NEK9 | 1.02460259 |
55 | FES | 0.93679853 |
56 | PKN1 | 0.93546116 |
57 | ERN1 | 0.84854691 |
58 | GRK7 | 0.84537727 |
59 | RPS6KA4 | 0.78786211 |
60 | TEC | 0.77080049 |
61 | SIK2 | 0.76512108 |
62 | MAPKAPK2 | 0.72940390 |
63 | LRRK2 | 0.71936628 |
64 | PRKCQ | 0.71857437 |
65 | FGR | 0.69117336 |
66 | ACVR1B | 0.67961908 |
67 | EIF2AK2 | 0.67604610 |
68 | TYRO3 | 0.66490740 |
69 | MAP3K3 | 0.63648073 |
70 | EIF2AK3 | 0.59869938 |
71 | PRKCD | 0.59310057 |
72 | CAMK1G | 0.58592312 |
73 | IRAK1 | 0.58237558 |
74 | MARK3 | 0.58202809 |
75 | ABL1 | 0.58081636 |
76 | EGFR | 0.56649641 |
77 | YES1 | 0.56001187 |
78 | ABL2 | 0.52631857 |
79 | DAPK2 | 0.52233119 |
80 | GSK3A | 0.51544743 |
81 | SCYL2 | 0.51516872 |
82 | SIK3 | 0.51124525 |
83 | MOS | 0.49880513 |
84 | NLK | 0.45948875 |
85 | MAP3K9 | 0.45614555 |
86 | FLT3 | 0.44667145 |
87 | STK24 | 0.41963691 |
88 | PTK6 | 0.41496349 |
89 | MAP3K1 | 0.40685647 |
90 | PDGFRB | 0.40568554 |
91 | CLK1 | 0.39963603 |
92 | MAP3K5 | 0.39469880 |
93 | MAP3K11 | 0.38606313 |
94 | PRKAA2 | 0.37106206 |
95 | PDPK1 | 0.36046195 |
96 | RPS6KA5 | 0.34414621 |
97 | INSR | 0.34409211 |
98 | CDK6 | 0.33856444 |
99 | CAMKK2 | 0.32821701 |
100 | RPS6KL1 | 0.31586524 |
101 | RPS6KC1 | 0.31586524 |
102 | TNK2 | 0.29325361 |
103 | SGK1 | 0.29154828 |
104 | MAP2K2 | 0.29080990 |
105 | MAPK12 | 0.28981958 |
106 | FYN | 0.28399426 |
107 | ALK | 0.27302481 |
108 | CDK4 | 0.26469697 |
109 | TSSK6 | 0.25861161 |
110 | BMX | 0.25609815 |
111 | ARAF | 0.25154930 |
112 | MAPK7 | 0.25152634 |
113 | RPS6KA6 | 0.25042735 |
114 | HIPK2 | 0.24907899 |
115 | IGF1R | 0.24756688 |
116 | RET | 0.24567626 |
117 | STK4 | 0.24382930 |
118 | PDK1 | 0.24160048 |
119 | DYRK1B | 0.23620838 |
120 | TESK2 | 0.23269436 |
121 | MAP2K6 | 0.23146790 |
122 | RPS6KA1 | 0.22008187 |
123 | STK11 | 0.21842894 |
124 | PRKCZ | 0.20038464 |
125 | MAPK4 | 0.18499171 |
126 | TRIB3 | 0.18361879 |
127 | DAPK3 | 0.18024534 |
128 | MAPK3 | 0.17986054 |
129 | PDGFRA | 0.17051400 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.12033987 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.97935896 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.94409211 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.82146210 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.60329680 |
6 | Allograft rejection_Homo sapiens_hsa05330 | 2.54710792 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.52533240 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50023452 |
9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.15044501 |
10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.12498256 |
11 | Measles_Homo sapiens_hsa05162 | 2.10108710 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.07145650 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04042122 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00796444 |
15 | Pertussis_Homo sapiens_hsa05133 | 1.99773755 |
16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.96126034 |
17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.92823812 |
18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.88749189 |
19 | Tuberculosis_Homo sapiens_hsa05152 | 1.82973952 |
20 | Legionellosis_Homo sapiens_hsa05134 | 1.82003389 |
21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.81248949 |
22 | Apoptosis_Homo sapiens_hsa04210 | 1.70093041 |
23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68060622 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.65922326 |
25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.65440298 |
26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.62860003 |
27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54386085 |
28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50763023 |
29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49126526 |
30 | Shigellosis_Homo sapiens_hsa05131 | 1.48127842 |
31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44346013 |
32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43045952 |
33 | Malaria_Homo sapiens_hsa05144 | 1.42868057 |
34 | Lysosome_Homo sapiens_hsa04142 | 1.41782117 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39878264 |
36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39721022 |
37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.37840411 |
38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36336027 |
39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33130715 |
40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27081249 |
41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26419023 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.22684701 |
43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20326360 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.17848822 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 1.14955699 |
46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09246932 |
47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08111878 |
48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07055672 |
49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02094092 |
50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99673792 |
51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97042187 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.96205585 |
53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95908261 |
54 | Phagosome_Homo sapiens_hsa04145 | 0.94592491 |
55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94463753 |
56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93271119 |
57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93233380 |
58 | Asthma_Homo sapiens_hsa05310 | 0.91547470 |
59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91321549 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85870029 |
61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82590216 |
62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82234566 |
63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77385903 |
64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73303661 |
65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70341179 |
66 | Platelet activation_Homo sapiens_hsa04611 | 0.69844137 |
67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69158425 |
68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64381673 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.62537208 |
70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62353627 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61685384 |
72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61566267 |
73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61120575 |
74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58805367 |
75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56334023 |
76 | Amoebiasis_Homo sapiens_hsa05146 | 0.54912091 |
77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52569855 |
78 | Bladder cancer_Homo sapiens_hsa05219 | 0.52274276 |
79 | Endocytosis_Homo sapiens_hsa04144 | 0.51623437 |
80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48589310 |
81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48440025 |
82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46436834 |
83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44920280 |
84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44758600 |
85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44637939 |
86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44216298 |
87 | Insulin resistance_Homo sapiens_hsa04931 | 0.41526494 |
88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41092460 |
89 | Prostate cancer_Homo sapiens_hsa05215 | 0.39814672 |
90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39205996 |
91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38651264 |
92 | Glioma_Homo sapiens_hsa05214 | 0.38098246 |
93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33986251 |
94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33623005 |
95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33602707 |
96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33349362 |
97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32372626 |
98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32244713 |
99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31610442 |
100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31386499 |
101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29324527 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25661221 |
103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25474431 |
104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.25172122 |
105 | Mineral absorption_Homo sapiens_hsa04978 | 0.24093034 |
106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22683551 |
107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.21398111 |
108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20121877 |
109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.16669384 |
110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16585011 |
111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11101606 |
112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.10641024 |
113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10106698 |
114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.03615914 |
115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.01557232 |